Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase III Trial of Adjuvant Capecitabine After Standard Neo-/Adjuvant Chemotherapy in Patients With Early Triple-Negative Breast Cancer (GEICAM/2003-11_CIBOMA/2004-01).
Lluch A, Barrios CH, Torrecillas L, Ruiz-Borrego M, Bines J, Segalla J, Guerrero-Zotano Á, García-Sáenz JA, Torres R, de la Haba J, García-Martínez E, Gómez HL, Llombart A, Bofill JS, Baena-Cañada JM, Barnadas A, Calvo L, Pérez-Michel L, Ramos M, Fernández I, Rodríguez-Lescure Á, Cárdenas J, Vinholes J, Martínez de Dueñas E, Godes MJ, Seguí MA, Antón A, López-Álvarez P, Moncayo J, Amorim G, Villar E, Reyes S, Sampaio C, Cardemil B, Escudero MJ, Bezares S, Carrasco E, Martín M; GEICAM Spanish Breast Cancer Group; CIBOMA (Iberoamerican Coalition for Research in Breast Oncology); LACOG (Latin American Cooperative Oncology Group). Lluch A, et al. Among authors: amorim g. J Clin Oncol. 2020 Jan 20;38(3):203-213. doi: 10.1200/JCO.19.00904. Epub 2019 Dec 5. J Clin Oncol. 2020. PMID: 31804894 Free PMC article. Clinical Trial.
Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE).
Bachelot T, Ciruelos E, Schneeweiss A, Puglisi F, Peretz-Yablonski T, Bondarenko I, Paluch-Shimon S, Wardley A, Merot JL, du Toit Y, Easton V, Lindegger N, Miles D; PERUSE investigators. Bachelot T, et al. Ann Oncol. 2019 May 1;30(5):766-773. doi: 10.1093/annonc/mdz061. Ann Oncol. 2019. PMID: 30796821 Free article. Clinical Trial.
Treatment patterns and healthcare resource utilization for triple negative breast cancer in the Brazilian private healthcare system: a database study.
Carlos Souto Maior Borba MA, de Mendonça Batista P, Falcão Almeida M, do Carmo Rego MA, Brandão Serra F, Barbour Oliveira JC, Nakajima K, Silva Julian G, Amorim G. Carlos Souto Maior Borba MA, et al. Among authors: amorim g. Sci Rep. 2023 Sep 22;13(1):15785. doi: 10.1038/s41598-023-43131-9. Sci Rep. 2023. PMID: 37737435 Free PMC article.
Cost-effectiveness of ribociclib for premenopausal or perimenopausal women with HR+/HER2- advanced breast cancer: a Brazilian public health care system perspective.
Rosa DD, Magliano CADS, Simon SD, Amorim G, Reinert T, Landeiro L, Gagliato DM, Exman P, Argolo D, Guilgen G, Mano M, Testa L, Liedke P, Barroso R, Sasse M, Buehler AM. Rosa DD, et al. Among authors: amorim g. Ther Adv Med Oncol. 2022 Jun 20;14:17588359221100865. doi: 10.1177/17588359221100865. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 36339925 Free PMC article.
Beyond October, Beyond Pink: A Year-Round Revelation for Women's Breast Health.
Kumar R, Mardones M, Costa L, Saini S, Villarreal-Garza C, Martinez-Cannon BA, Manjunath G, Sinha S, Han Z, Arora A, Ferreira AM, Larsen L, Hairabedian S, Curry T, Borge H, Amorim G, Shimizu C, Zamre V, Toi M, Fisher PB, Clarke R, Lipton A, Martin M, Warner E. Kumar R, et al. Among authors: amorim g. J Womens Health (Larchmt). 2023 Nov;32(11):1143-1146. doi: 10.1089/jwh.2023.0663. Epub 2023 Oct 2. J Womens Health (Larchmt). 2023. PMID: 37787652 No abstract available.
Impact of COVID-19 pandemic on surgical volume and outcomes in a terciary care center in Brazil.
Bittencourt PL, Aragão GVP, Valverde Filho MT, Amorim GAF, Castro ILV, Santana JO, Costa LC, Muniz BSM, Silva VRS, Codes L, Zollinger CC, Andraus W. Bittencourt PL, et al. Among authors: amorim gaf. Rev Col Bras Cir. 2024 May 6;51:e20243678. doi: 10.1590/0100-6991e-20243678-en. eCollection 2024. Rev Col Bras Cir. 2024. PMID: 38716917 Free article. English, Portuguese.
Time spent at health facility is a key driver of patient satisfaction, but did not influence retention to HIV care: A serial cross-sectional study in Mozambique.
De Schacht C, Amorim G, Calvo L, Ntasis E, Van Rompaey S, Matsimbe J, Martinho S, Graves E, Sardella Alvim MF, Green A, Kassim H, Carlos IC, Wester CW, Audet CM. De Schacht C, et al. Among authors: amorim g. PLoS One. 2024 Apr 18;19(4):e0299282. doi: 10.1371/journal.pone.0299282. eCollection 2024. PLoS One. 2024. PMID: 38635537 Free PMC article.
107 results